Navigation Links
Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
Date:7/22/2008

CEO Geoffrey Allan Will Stress the Importance to Patients of Passing a

Follow- On Biologics Approval Pathway

RICHMOND, Va., July 22 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq CM: INSM) a developer of follow-on biologics and biopharmaceuticals, today announced that Geoffrey Allan, Ph.D., CEO of Insmed, will present at a Congressional briefing on Friday, July 25th, 2008 to discuss the significant need for establishing an approval pathway for follow-on biologics (FOB) and share recent company developments.

The briefing, entitled "The Future of Medicine: How to Lower Costs and Improve Patient Access with Generic Biologics," will be held at the U.S. Capitol Complex in Washington, D.C. Dr. Allan will detail Insmed's unique capabilities related to the development of follow-on biologics. Specifically, he will discuss the Company's latest developments, including release of Phase I data demonstrating the bioequivalence of Insmed's first FOB candidate, INS- 19, to Amgen's Neupogen(R) (patent expiration in 2013), the Company's affiliation with The Honorable Bill Thomas and the benefits of potential price competition and increased innovation in the field of biotechnology.

Insmed intends to request a meeting with the FDA to discuss potentially initiating a Phase III clinical trial program for INS-19. The Company also plans to initiate a Phase I trial for Insmed's second follow-on biologic product, INS-20, a follow-on of Neulasta(R) (patent expiration in 2015) in the fourth quarter of 2008. The two approved biologics represented combined 2007 worldwide sales of over $4 billion. Insmed plans to launch its follow-on biologic versions of these drugs on expiration of the relevant innovator patents.

The Follow-on Biologics Market

According to published reports, an estimated $10 billion worth of biologic drugs are expected to come off patent by 2010, with an additional $10 billion by 2015. FOBs would provide safe and effec
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
2. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
3. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
4. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
5. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
6. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
7. Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer
8. Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
9. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
10. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
11. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , HARRISBURG, Pa., Nov. 20 /PRNewswire-USNew...viding free H1N1 flu shots to members of priority ...ccine. ,, A total of 18 clinics are being held ... from 2 p.m. to 8 p.m. Hours on Saturday, Nov. 21,...clinics will operate from 2 p.m. to 8 p.m. ,, ...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Repor...eport is available in its catalogue. ,, Global...easing Adoption to Drive Growth ,, http://ww...-Blood-Glucose-Market-(SMBG )-Increasing-Adoption-..._medium=pr&utm_campaign=prnewswire ,, Des...
(Date:11/20/2009)... , NEW YORK, Nov. 20 ,...earch report is available in its catalogue. ,, ...asts to 2015 ,, http://www.reportlinker.com/...nd-Forecasts-to-2015.html#utm_source=prnewswire&am..., Description ,, India Medical Equipment Mark...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13RadMD Offers Tips on Optimizing Clinical Trial Efficiency 5741 1RadMD Offers Tips on Optimizing Clinical Trial Efficiency 5741 2RadMD Offers Tips on Optimizing Clinical Trial Efficiency 5741 3Elsevier introduces Aesthetic Plastic Surgery 60149 1Elsevier introduces Aesthetic Plastic Surgery 60149 2The skeleton 3A Size matters 10538 1The skeleton 3A Size matters 10538 2
... Weekly Investigational Diabetes Therapy Also Impr...m Exenatide Taken Twice a Day, SAN FRANCISCO, Jun... Eli Lilly and Company (NYSE: LLY ), and Alkermes...om a 52-week open-label clinical,study that showed...long-acting release formulation of exenatide. Pati...
...O, June 9 Two long-term, large-scale and,independ...s in people with,type 2 diabetes enrolled more tha...maleate) and provide more than 20,000 patient year...ans Affairs Diabetes Trial,(VADT), through two sep...om,VADT, there is no evidence to suggest that use ...
Other Medicine Technology:After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 2Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 3Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R) 4
(Date:11/21/2009)... , LONDON, November 21, 2009 /PRNewswire-F...st Test Test Test Test Test Test Test Test Test Te...st Test Test Test Test Test Test,Test Test Test Te... More test More test More test More test More t...est More test More test More test More test More,t...
(Date:11/21/2009)... HAPPYneuron,s most popular ...n the iPhone and iPod Touch. , ...-- HAPPYneuron,s most popular and addictive game, ...d Touch. Split Words is designed to help banish th...SplitWords iPhone brain game challenges the brai...
(Date:11/21/2009)... Linwood Group ask whether t...n it be measured? , Londo...eveal that with up to one in three of the adult UK...sk of developing alcohol-related liver disease*, i...turning to rehabilitation programmes and residenti...
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswi...ging senators to modify health care reform legisla...ge regarding a health insurance individual coverag...d enforceable mandate will minimize adverse select...g rules prescribed by the bill. ,, "The individ...
(Date:11/20/2009)... Senators and Congressmen in...le Over their Health Care Vote , ...- Senators and congressmen running for re-election...litical guru Charlie Cook, may come to regret voti...are bill, according to a breaking Zogby Internatio...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
...raining Grants Help Companies Design, Prototype an...ciently , , AUSTIN, Texas, Feb. 9, 2009 National...will continue its investment to further medical d... thrive. A recent study of more than 1,000 medical...
...LE, Fla., Feb. 9 Availity, LLC, a leading,provide...nical health,information services, today announced...of real-time electronic eligibility and benefits a...ealth,Information Network, which securely exchange...
... The Beryl Companies, the nation,s leading health... growth in the year just concluded. In 2008, Beryl...ns with consumers across the country, launched a n...ned a record client retention rate of 97 percent, ...
...ove Your Heart Health Through Proper Oral Care , ...Heart Month, women throughout the U.S. will be mak.... To help support this national initiative and pro...s on empowering women by providing the knowledge a...
...ology Combines Capabilities of Multiple Lasers in ...Feb. 9 Sciton, Inc. announces the launch of the...ltiple, distinctive laser technologies into a sing...res as they become available, and provides revenue...
..., Feb. 9 Global multiservice public relations,age... live panel discussion,titled "Healthcare Communic...in a Highly Regulated Environment." The presentati...com/reg/events/healthcare-webcast.aspx . , Int...
Other Medicine News:Health News:National Instruments to Further Medical Device Development With Grants in 2009 2Health News:National Instruments to Further Medical Device Development With Grants in 2009 3Health News:National Instruments to Further Medical Device Development With Grants in 2009 4Health News:The Beryl Companies Adds Services, Clients for Record Year in 2008 2Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 2Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 3Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 4Health News:Sciton Unveils the JOULE Aesthetic Laser Platform for Physicians Battling the Economic Squeeze 2Health News:Sciton Unveils the JOULE Aesthetic Laser Platform for Physicians Battling the Economic Squeeze 3Health News:Sciton Unveils the JOULE Aesthetic Laser Platform for Physicians Battling the Economic Squeeze 4Health News:Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2
Infusion Cannula 2.5mm
Lacrimal Intubation Set
J Cortex Extrator - Angled Right
J Cannula
Medicine Products: